Unique ID issued by UMIN | UMIN000033174 |
---|---|
Receipt number | R000037779 |
Scientific Title | Double blind comparative study of effects of amino acids-enriched food on brain function in elderly subjects |
Date of disclosure of the study information | 2018/07/25 |
Last modified on | 2019/06/19 17:22:03 |
Double blind comparative study of effects of amino acids-enriched food on brain function in elderly subjects
Evaluation of effects of amino acids-enriched food on brain function in elderly subjects
Double blind comparative study of effects of amino acids-enriched food on brain function in elderly subjects
Evaluation of effects of amino acids-enriched food on brain function in elderly subjects
Japan |
Healthy subjects
Adult |
Others
NO
To examine the effect of amino acid-enriched foods on brain function in elderly subjects
Efficacy
Cognitive function Battery
*Secondary outcomes
SF-36, WHO-5-J, Questionnaire survey (Related to Activity, Cognitive decline, Social involvement, Care prevention, Social capital, Multidimensional Empathy Scale, VAS), Amino acids and other metabolites
*Safety
Adverse event, side effect, blood pressure, pulse rate, BMI, clinical test result
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Placebo
Low-dose amino acid-enriched food
Medium-dose amino acid-enriched food
55 | years-old | <= |
Not applicable |
Male and Female
1) Subjects whose MMSE-J score is 26 or higher, and MoCA-J score less than 30.
2) Subjects who have noticeable symptoms of memory loss or whose memory loss has been pointed out by others.
3) Subjects who provided written informed consent.
1) Individuals who have a history of mental or cerebrovascular diseases.
2) GDS-S-J score above 6.
3) Individuals who use medicines which may affect central nervous system except for sleeping pills.
4) Individuals who regularly intake supplements or functional foods which may affect cognitive function.
5) Individuals who have visual impairment or hearing impairment.
6) Individuals who have a history of alcohol dependence.
7) Individuals who are under medical treatment of cancer or cirrhosis of liver.
8) Dialysis patients.
9) Individuals who have allergy of milk or lactose intolerance.
10) Individuals with phenylketonuria.
11) Individuals who participate or will participate in other clinical studies.
12) Individuals who are assessed to be inappropriate by the principal investigator due to other reasons.
105
1st name | |
Middle name | |
Last name | Hiroyuki Suzuki |
Tokyo Metropolitan Institute of Gerontology
Research Team for Social Participation and Community Health
35-2 Sakae-cho, Itabashi-ku, Tokyo, Japan
03-3964-3241
suzukihy@tmig.or.jp
1st name | |
Middle name | |
Last name | Yoshika Komori |
KSO Corporation
Executive chairman
1-9-7 Shibaura, Minato-ku, Tokyo, Japan
03-3452-7733
yoshi@kso.co.jp
Tokyo Metropolitan Institute of Gerontology
AJINOMOTO CO., INC.
Profit organization
NO
地方独立行政法人東京都健康長寿医療センター研究所/Tokyo Metropolitan Institute of Gerontology.
2018 | Year | 07 | Month | 25 | Day |
Unpublished
Completed
2018 | Year | 05 | Month | 31 | Day |
2018 | Year | 06 | Month | 05 | Day |
2018 | Year | 09 | Month | 01 | Day |
2018 | Year | 12 | Month | 18 | Day |
2019 | Year | 05 | Month | 30 | Day |
2018 | Year | 06 | Month | 28 | Day |
2019 | Year | 06 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037779